WorkspaceResearch
LIVENPHARMACEUTICALSAlpha Score••Free accountSep-26

Liven Pharma Limited

Shariah compliant
Last close
Rs47.64
+10.00%
3 monthsAs of 19 Nov
BusinessGoodGrowthShranklast yearValueCore planHealthStrongDividendNone

Almost no debt, a good business and priced below its peers. No read is against it.

Working

  • P/E 0.0 against a sector median of 11.9.
  • Debt is 3% of equity in the latest quarter.
  • Revenue up 62% on the same quarter last year.

To watch

  • Free cash flow negative, Rs 18m out last year, after Rs 152m the year before.
  • A loss of Rs 31m in the latest year, after a loss of Rs 12m over three years.
Full analysis · free account

Keep reading LIVEN: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, LIVEN's sales rose 62% to Rs 14.3mn, from Rs 8.8mn, and profit after tax was a loss of Rs 7.4mn, against a loss of Rs 30.2mn (compared with Jul–Sep 2025).

Earnings per share were -Rs 0.07, against -Rs 0.32 a year earlier.

Dividend payout
0%
of earnings
Return on equity
-1%
Net margin
-8.0%
last 12 months
Debt to equity
0.03

LIVEN quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 14.3mn-Rs 7.4mn-51.6%-Rs 0.07—
Apr–Jun 2026Rs 13.2mn-Rs 25.2mn-191.5%-Rs 0.23—
Jan–Mar 2026Rs 29.2mn-Rs 4.0mn-13.5%-Rs 0.03—
Oct–Dec 2025Rs 54.6mnRs 28.2mn51.7%Rs 0.30—
Jul–Sep 2025Rs 8.8mn-Rs 30.2mn-341.9%-Rs 0.32—
Apr–Jun 2025Rs 6.5mn-Rs 695.3mn-10727.4%-Rs 10.76—
Jan–Mar 2025Rs 14.8mn-Rs 9.6mn-65.2%-Rs 0.13—
Oct–Dec 2024Rs 17.1mn-Rs 9.5mn-55.4%-Rs 0.20—

LIVEN annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Jun 2026Rs 105.8mn-Rs 31.1mn-Rs 0.28—
Year to Jun 2025Rs 127.3mn-Rs 585.7mn-Rs 8.44—
Year to Jun 2024—Rs 41.7mnRs 3.44—
Year to Jun 2023—-Rs 12.3mn-Rs 1.02—
Year to Jun 2022—-Rs 14.3mn-Rs 1.18—

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 1.2bn
Shareholders' equity
Rs 978.1mn
Cash & bank
Rs 8.4mn
Total debt
Rs 33.1mn
Current ratio
2.58
3-month high
Rs 47.64
3-month low
Rs 29.01
1-month change
+51.5%
3-month change
+40.8%

Read more about LIVEN

Other pharmaceuticals companies

LIVEN: common questions

What is LIVEN's share price?

Liven Pharma Limited (LIVEN) last closed at Rs 47.64 on the Pakistan Stock Exchange.

Does LIVEN pay a dividend?

Liven Pharma Limited reported no dividend for the year to Jun 2026.

What were LIVEN's latest results?

In the Jul–Sep 2026 quarter, LIVEN's sales rose 62% to Rs 14.3mn, from Rs 8.8mn, and profit after tax was a loss of Rs 7.4mn, against a loss of Rs 30.2mn (compared with Jul–Sep 2025).

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.